Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

9MWS

Structure of human endothelial nitric oxide synthase heme domain bound with N-(3-(2-((3-(thiazole-5-carboximidamido)benzyl)amino)ethyl)phenyl)thiazole-5-carboximidamide

This is a non-PDB format compatible entry.
Summary for 9MWS
Entry DOI10.2210/pdb9mws/pdb
DescriptorNitric oxide synthase, endothelial, CALCIUM ION, PROTOPORPHYRIN IX CONTAINING FE, ... (11 entities in total)
Functional Keywordsnitric oxide synthase inhibitor binding, oxidoreductase
Biological sourceHomo sapiens (human)
Total number of polymer chains4
Total formula weight205843.66
Authors
Li, H.,Poulos, T.L. (deposition date: 2025-01-17, release date: 2025-11-26, Last modification date: 2026-04-01)
Primary citationAwasthi, A.,Patel, A.,Li, H.,Kang, K.M.,Hardy, C.D.,Ansari, A.,Nowar, R.,Hasan, M.E.,Yang, S.,Poulos, T.L.,Silverman, R.B.
New Inhibitors of Neuronal Nitric Oxide Synthase for the Treatment of Melanoma.
J.Med.Chem., 69:2310-2329, 2026
Cited by
PubMed Abstract: In 2024, an estimated 100,640 new cases of invasive melanoma were diagnosed in the U.S., with 9290 deaths. Our previous studies revealed that neuronal nitric oxide synthase (nNOS) derived nitric oxide plays a critical role in melanoma progression, making nNOS inhibition a promising strategy. High structural similarity among NOS isoforms requires careful design of nNOS inhibitors to avoid off-target effects. Our previous lead, HH044, demonstrated potent antimelanoma activity but exhibited only moderate nNOS selectivity. Here, we utilized a structure-based approach to design nNOS inhibitors that promote interactions with human nNOS-specific residue His342. Compound exhibited inhibition of both human ( = 1.7 nM) and rat nNOS ( = 2.3 nM), with 5654-fold selectivity over human eNOS and 250-fold selectivity over iNOS. X-ray crystallography and molecular modeling revealed a novel SAR, forming the basis for nNOS inhibition and providing a foundation for further innovative design of nNOS inhibitors for melanoma treatment.
PubMed: 41615895
DOI: 10.1021/acs.jmedchem.5c02154
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (1.899 Å)
Structure validation

251422

PDB entries from 2026-04-01

PDB statisticsPDBj update infoContact PDBjnumon